116 related articles for article (PubMed ID: 10071547)
1. Effect of transurethral resection of prostate on plasma hormone levels in benign prostatic hyperplasia.
Sasagawa I; Nakada T; Suzuki H; Adachi Y; Adachi M
Br J Urol; 1993 Nov; 72(5 Pt 1):611-4. PubMed ID: 10071547
[TBL] [Abstract][Full Text] [Related]
2. Effects of transurethral prostate resection and transurethral laser prostatectomy on plasma hormone levels.
Türkölmez K; Bozlu M; Sarica K; Gemalmaz H; Ozdiler E; Gögüş O
Urol Int; 1998; 61(3):162-7. PubMed ID: 9933837
[TBL] [Abstract][Full Text] [Related]
3. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection.
Wu Y; Pan H; Wang WM; Xu D; Zhang L; Gu ZQ; Bai Q; Qi J; Huang HF
Asian J Androl; 2017; 19(2):230-233. PubMed ID: 26763548
[TBL] [Abstract][Full Text] [Related]
4. The hormonal status of patients with benign prostatic hypertrophy: FSH, LH, TSH and prolactin responses to releasing hormones.
Hammond GL; Lukkarinen O; Vihko P; Kontturi M; Vihko R
Clin Endocrinol (Oxf); 1979 Jun; 10(6):545-52. PubMed ID: 89919
[No Abstract] [Full Text] [Related]
5. Impact of radical prostatectomy and TURP on the hypothalamic-pituitary-gonadal hormone axis.
Madersbacher S; Schatzl G; Bieglmayer C; Reiter WJ; Gassner C; Berger P; Zidek T; Marberger M
Urology; 2002 Nov; 60(5):869-74. PubMed ID: 12429318
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of follicle stimulating hormone, luteinizing hormone, prolactin, testosterone, 5 alpha-dihydrotestosterone, 5 alpha-androstane-3 alpha, 17 beta-diol, 5 alpha-androstane-3 beta, 17 beta-diol, and 17 beta-estradiol from male beagles with spontaneous or induced benign prostatic hyperplasia.
Cochran RC; Ewing LL; Niswender GD
Invest Urol; 1981 Nov; 19(3):142-7. PubMed ID: 6170603
[TBL] [Abstract][Full Text] [Related]
7. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
[TBL] [Abstract][Full Text] [Related]
8. Plasma steroid and protein hormone concentrations in patients with benign prostatic hypertrophy and in normal men.
Ortega E; Ruiz E; Mendoza MC; Martin-Andres A; Osorio C
Experientia; 1979 Jun; 35(6):844-5. PubMed ID: 89045
[TBL] [Abstract][Full Text] [Related]
9. [Pre- and post-prostatectomy variation and supplement of sexual hormones in patients with benign prostatic hyperplasia].
Ren XM; Ying J; Yao DH; Jiang YQ; Xu MX
Zhonghua Nan Ke Xue; 2005 Jan; 11(1):50-2, 55. PubMed ID: 15704683
[TBL] [Abstract][Full Text] [Related]
10. Changes of pituitary, adrenal and gonadal hormones during competition among female soccer players.
Aizawa K; Nakahori C; Akimoto T; Kimura F; Hayashi K; Kono I; Mesaki N
J Sports Med Phys Fitness; 2006 Jun; 46(2):322-7. PubMed ID: 16823365
[TBL] [Abstract][Full Text] [Related]
11. Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection.
Phadke MA; Vanage GR; Sheth AR
Prostate; 1987; 10(2):115-22. PubMed ID: 2436203
[TBL] [Abstract][Full Text] [Related]
12. Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.
Uygur MC; Arik AI; Altuğ U; Erol D
Steroids; 1998 Apr; 63(4):208-13. PubMed ID: 9589555
[TBL] [Abstract][Full Text] [Related]
13. Serum FSH, LH and prolactin in normal males and patients with prostatic diseases.
Hammond GL; Kontturi M; Määttälä P; Puukka M; Vihko R
Clin Endocrinol (Oxf); 1977 Aug; 7(2):129-35. PubMed ID: 70287
[TBL] [Abstract][Full Text] [Related]
14. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation.
Seehofer D; Steinmueller T; Graef KJ; Rayes N; Wiegand W; Tullius SG; Settmacher U; Neuhaus P
Ann Transplant; 2002; 7(2):32-7. PubMed ID: 12416470
[TBL] [Abstract][Full Text] [Related]
15. [Hormonal status of patients with uterine cancer during surgical treatment].
Musina RKh; Kiseleva NS; Modnikov OP
Vopr Onkol; 1987; 33(8):99-102. PubMed ID: 2820150
[TBL] [Abstract][Full Text] [Related]
16. Temporal relationships between the circadian rhythmicity in plasma levels of pituitary hormones and in hypothalamic concentrations of releasing factors.
Szafarczyk A; Hery M; Laplante E; Ixart G; Assenmacher I; Kordon C
Neuroendocrinology; 1980 Jun; 30(6):369-76. PubMed ID: 6247669
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal environment and antiandrogenic treatment in benign prostatic hypertrophy].
Katayama T; Umeda K; Kazama T
Hinyokika Kiyo; 1986 Nov; 32(11):1584-9. PubMed ID: 2435122
[TBL] [Abstract][Full Text] [Related]
18. Influence of radical prostatectomy on serum hormone levels.
Miller LR; Partin AW; Chan DW; Bruzek DJ; Dobs AS; Epstein JI; Walsh PC
J Urol; 1998 Aug; 160(2):449-53. PubMed ID: 9679896
[TBL] [Abstract][Full Text] [Related]
19. Plasma prolactin, GH, LH, FSH, TSH and testosterone during treatment of prostatic carcinoma with oestrogens.
Boyns AR; Cole EN; Phillips ME; Hillier SG; Cameron EH; Griffiths K; Shahmanesh M; Feneley RC; Hartog M
Eur J Cancer (1965); 1974 Jul; 10(7):445-9. PubMed ID: 4376085
[No Abstract] [Full Text] [Related]
20. The effect of antiestrogen, antiandrogen, and the prolactin inhibitor 2 bromo-alpha-ergocriptine on the stromal tissue of human benign prostatic hyperplasia. Correlation of stereological data and plasma hormones.
Bartsch G; Oberholzer M; Rohr HP
Invest Urol; 1981 Jan; 18(4):308-12. PubMed ID: 6161105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
